Home
December 2008 January 2009 February 2009
Su Mo Tu We Th Fr Sa
Week 1 1 2 3
Week 2 4 5 6 7 8 9 10
Week 3 11 12 13 14 15 16 17
Week 4 18 19 20 21 22 23 24
Week 5 25 26 27 28 29 30 31

European Urology - Preoperative and Intraoperative Risk Factors for Side-Specific Positive Surgical Margins in Laparoscopic Radical Prostatectomy for Prostate Cancer Show Comments PDF Print E-mail
  
Monday, 05 March 2007
Volume 51, Issue 3, Pages 764-771 (March 2007)

1. Introduction:


Surgical margin (SM) status is the only pathologic variable that can be objectively measured to determine complete tumour resection
. A positive surgical margin (PSM) has been proven to be associated with biochemical recurrence (BCR) rates of 50% at 10 yr after radical prostatectomy (RP) [1]. In addition, the risk of BCR after RP is two to four times greater if the margin is positive, even after excluding patients who received adjuvant therapy [2].

Serum prostate-specific antigen (PSA), clinical stage, and biopsy Gleason can predict PSMs preoperatively [3], [4], [5], [6]. Surgical technique and individual surgeon's expertise also play an important role in the incidence of PSM in open RP after controlling for other clinical and pathologic variables [2]. Of these prognostic factors, only surgical technique can be modified and tailored to the prostate side(s) where clinical and biopsy findings suggest a higher burden of disease.

Nonetheless, prior studies on the association between degree of neurovascular bundle (NVB) dissection and PSM rates failed to show if the PSM was on the prostate side where the NVB was excised or on the contralateral side, particularly in patients who had unilateral NVB resection or in those with unilateral prostate cancer (pT2a) [6], [7], [8]. That is why the present study seeks to evaluate the association of both preoperative clinical factors and degree of NVB dissection with PSM by prostate side (side-specific analysis) among patients undergoing laparoscopic radical prostatectomy (LRP) for clinically localized prostate cancer.

Over the last 5 yr, LRP, with or without robotic assistance, has quickly become popular among urologists, and it is therefore believed that there is a need for accurate identification of variables predictive of PSMs in patients undergoing LRP.

2. Material and methods

Between October 2002 and April 2005, 411 patients were treated with transperitoneal LRP by a single surgeon at our institution [15]. Four patients who received neoadjuvant therapy were excluded, leaving 407 patients with 814 evaluable prostate sides (right and left). Of these, 728 prostate sides that harboured prostate cancer in the final pathology analysis, making these patients at risk for PSM, composed the study population. Prostate sides without prostate cancer in the final report were excluded because by definition they will always have a negative SM irrespective of the degree of NVB dissection performed (Fig. 1).



Fig. 1. Midglandular axial section of a prostate mapping inked with hematoxylin-eosin demonstrates that it does not matter how inaccurate the neurovascular bundle dissection may have been on one side and that it will always be called a “negative margin” as long as there are no malignant cells in contact with ink. Absence of cancer cells on that prostate half works as a surrogate for this, explaining why prostate sides without cancer cells were excluded from the analysis. Cancer cell are present in the right peripheral zone (D). The red dot shows an area of extracapsular extension. The arrow demonstrates an area of prostate amputation on the left lateral face. On the basis of the definition of positive margin (see text), this zone is considered a “negative margin” despite the capsular violation.

For this analysis, clinical stage was categorized into side-specific palpable and nonpalpable nodule on preoperative physical examination. Serum PSA level was routinely measured with the use of the Hybritech Tandem-R PSA assay (Hybritech, San Diego, CA, USA).

All outside biopsy specimens were reviewed by specialized uropathologists at our institution. We recorded side-specific Gleason score (sum of the primary and secondary patterns) and the greatest percentage of cancer among all positive needle cores for each side.

Endorectal coil magnetic resonance imaging (MRI) was performed on 379 (93%) patients at least 4 wk after the prostate biopsy. The MRI technique and extracapsular extension (ECE) criteria have already been described [8]. Prostate volume on MRI was calculated with the ellipsoid formula: 0.52×width×length×height.

The degree of NVB dissection was determined by the operating surgeon on the basis of the plane where the dissection took place [9] and registered immediately after completion of the procedure (Fig. 2).



Fig. 2. T2-weighted magnetic resonance imaging axial section at the midprostate showing the different degrees of neurovascular bundle (NVB) dissection. The intrafascial (Intra) dissection follows the plane between the prostatic capsule and the prostatic fascia at the posterolateral angle of the gland. The interfascial (Inter) dissection is performed lateral to the prostatic fascia into the thickness of the NVB. The extrafascial (Extra) dissection is carried out lateral to the entire NVB.

Intrafascial dissection (complete NVB preservation) was defined as a NVB dissection that followed the plane between the prostatic capsule and the prostatic fascia at the posterolateral angle of the gland only. In this case, the NVB was completely “preserved,” and the medial aspect of the NVB (side in contact with the prostate) was covered by the prostatic fascia. In this type of dissection, as the prostate is excised, the Dennonvilliers fascia will remain on the posterior surface of the prostate, but the posterolateral surfaces of the prostate where the NVBs resided will be bare of both prostatic and Dennonvilliers fascias. Prostatic fascia also remains covering the anterolateral aspect of the prostate (Fig. 2, Fig. 3). Interfascial dissection (partial NVB preservation) was defined as a NVB dissection lateral to the prostatic fascia into the thickness of the NVB. In this case the NVB was partially “damaged,” and the prostatic fascia stayed on the prostate side rather than covering the medial aspect of the NVB (Fig. 2, Fig. 3). We considered extrafascial dissection (complete/almost complete NVB damage) when the dissection was carried out lateral to the entire NVB. In this case the NVB was completely or almost completely resected (Fig. 2, Fig. 3).


Fig. 3. Midglandular axial section of a prostate mapping inked with hematoxylin-eosin. Note in A the difference between intrafascial and interfascial techniques. B shows the difference between extrafascial technique and a “wider” interfascial dissection of the neurovascular bundles.

All radical prostatectomy specimens were sectioned with whole-mount technique by specialized uropathologists. A PSM was defined as tumour cells in contact with ink on the specimen. The Gleason system was used for histologic characterization and scored by the sum of the primary and secondary patterns.

A side-specific intrafascial dissection of the neurovascular bundle was usually performed in prostate sides with no palpable nodules, biopsy Gleason score 3+3 or 3+4, maximum percentage of positive biopsy ≤10% (depending on the location of such biopsy), one of three, or one or two of six positive cores, particularly when the positive cores were located medially, or in the absence of suspected ECE on MRI. However, a prostate side with a single positive biopsy with Gleason score 4+3 or 4+4, or a prostate side with a maximum percentage of cancer >10% compromising a medial core without signs of ECE may be suitable for an intrafascial dissection. These criteria should not be taken as a strict rule but as a general guideline.

2.1. Statistical methods

Multivariable associations between preoperative variables and SM status were analyzed with the use of logistic regression. Generalized estimating equations were used to account for patients contributing more than one prostate side to the analysis. We prespecified a single multivariable analysis that included preoperative serum PSA levels, clinical stage (palpable vs. nonpalpable nodule), biopsy Gleason grade (≤6 vs. 7 vs. 8–10), prostate volume on MRI, degree of NVB dissection (intrafascial vs. interfascial vs. extrafascial), and suspicion of ECE on MRI. Because of incomplete data, the side-specific greatest percentage of cancer among all positive needle cores was analyzed by an exploratory univariate analysis. Analysis of variance and comparison of proportions were used when indicated. All tests were two-sided, with p≤0.05 considered statistically significant. Statistical analyses were conducted with the use of Stata, version 8.2 (Stata Corp, College Station,TX, USA).

3. Results

One or more PSMs were identified in 59 of the 728 prostate sides. Eight prostate sides had more than one PSM in the ipsilateral lobe, making a total of 51 distinct PSMs (Table 1). Table 2 details the locations of the PSM. The largest difference between left and right sides was observed at the apex, where left-sided tumours had twice as many PSMs. Table 3, Table 4show the preoperative clinical characteristics of patients (age, body mass index [BMI], serum PSA, and prostate volume) and of prostate sides (maximum percentage of tumour in cores, biopsy Gleason sum, suspected ECE on MRI, degree of NVB dissection, and clinical stage), subdivided by SM status.

Table 1.

Side of tumour and positive surgical margins

Surgical margin status n (%) Total
Negative Positive
No. of patients 358 (88%) 49 (12%) 407
Prostate sides with cancer (i.e., at risk of PSM) 677 (93%) 51 (7%) 728
Unilateral tumours
Right-sided tumours 38 (90%) 4 (10%) 42
Left-sided tumours 43 (98%) 1 (2%) 44
Total 81 (94%) 5 (6%) 86
Bilateral tumours
Right-sided tumours 299 (94%) 20 (6%) 319
Left-sided tumours 297 (92%) 26 (8%) 323
Total 596 (93%) 46 (7%) 642

PSM: positive surgical margin.


Table 2.

Positive surgical margin location by tumour side

Location Right (n [%]) (n=361) Left (n [%]) (n=367)
Anterior 4 (1.1) 5 (1.4)
Apex 8 (2.2) 15 (4.1)
Posterior 14 (3.9) 11 (3.0)
Bladder neck 0 (0) 1 (0.3)
Lateral 0 (0) 1 (0.3)
Total* 26 (7.2) 33 (9.0)

* Includes locations of multiple positive surgical margins in the ipsilateral lobe.


Table 3.

Preoperative variables of 407 patients who underwent laparoscopic radical prostatectomy for clinically localized prostate cancer

Characteristic Surgical margin status
Negative (n=375) Positive (n=32)
Age, yr 59 (54, 64) 59 (55, 65)
Body mass index 27 (25, 30) 27 (26, 30)
Preoperative PSA, ng/ml 5.3 (4.1, 7.0) 5.5 (4.6, 9.4)
Prostate volume on MRI, cc 33 (25, 44) 27 (19, 37)

MRI=magnetic resonance imaging; PSA=prostate-specific antigen.

Data are given as median (interquartile range).


Table 4.

Preoperative variables and surgical margin status of 728 prostate sides that contained cancer

Surgical margin status
Negative (n=677) Positive (n=51)
Median maximum % of tumour in cores (interquartile range) 10 (5, 30) 25 (11, 50)
ECE suspected on MRI, n (%)
No 460 (93) 32 (7)
Yes 189 (91) 19 (9)
Biopsy Gleason sum, n (%)
≤6 535 (95) 29 (5)
7 120 (86) 19 (14)
≥8 22 (88) 3 (12)
Neurovascular bundle dissection, n (%)
Intrafascial 562 (95) 31 (5)
Interfascial 70 (81) 16 (19)
Extrafascial 45 (92) 4 (8)
Clinical stage, n (%)
Absent nodule (T1c) 584 (93) 43 (7)
Palpable nodule (T2 or T3) 93 (92) 8 (8)

ECE=extracapsular extension; MRI=magnetic resonance imaging.

* 91 patients had no available data for maximum % of tumour in cores.

18 patients had no available data for ECE location.


The specimen pathologic evaluation showed that 492 (70%) of the 700 prostate sides that underwent MRI had the cancer confined within the prostate capsule and 208 (30%) had ECE. The side-specific PSM rate was 7% for the organ-confined tumours and 9% for those with ECE.

On multivariable analysis, the variables associated with a higher probability of PSM were higher preoperative PSA (p=0.02), Gleason grade 7 compared with ≤6 (p=0.001), interfascial NVB dissection compared with intrafascial dissection (p<0.0005), and smaller prostate volume (p=0.01) (Table 5). Although interfascial dissection of the NVB was independently associated with an increased risk of PSM compared with intrafascial dissection (p=0.01), we found no significant difference between extrafascial and intrafascial dissection (p=0.7). In addition, biopsy Gleason sum 7 (p=0.04), but not Gleason ≥8 (p=0.6), was significantly associated with increased risk of PSM compared with Gleason ≤6.

Table 5.

Multivariable analyses to assess association with positive surgical margins

Multivariable analysis (n=681)
Odds ratio 95%CI p value
Preoperative PSA 1.15 1.04, 1.28 0.01
Biopsy Gleason grade
≤6 Reference
7 2.39 1.06, 5.39 0.04
≥8 1.72 0.24, 12.14 0.6
Neurovascular bundle dissection
Intrafascial Reference
Interfascial 3.85 1.48, 9.98 0.01
Extrafascial 1.41 0.31, 6.49 0.7
Prostate volume on MRI 0.96 0.93, 0.99 0.01
ECE suspected on MRI
No Reference
Yes 0.95 0.40, 2.26 0.9
Clinical stage
Absent nodule (T1c) Reference
Palpable nodule (T2 or T3) 0.60 0.20, 1.80 0.4

CI=confidence interval; ECE=extracapsular extension; MRI=magnetic resonance imaging; PSA=prostate-specific antigen.


Table 6 shows in detail the occurrence of PSM by degree of NVB dissection, PSM location, and pathologic stage. The patients undergoing interfascial NVB dissection had higher proportions of PSM located at the apex and posterior aspects of the prostate in comparison with the intrafascial group, whereas the incidence of PSM on the anterior aspect did not vary. The proportion of PSM among prostate sides that underwent interfascial NVB dissections increased from 11% in pT2 to 30% in pT3 prostate sides. Because of incomplete data, the effect of greatest percentage of cancer in any positive needle core from a given prostate side was explored in a univariate way. A higher maximum percentage of cancer in any positive needle core was associated with a greater chance of a side-specific PSM (odds ratio [OR]: 1.02; 95% confidence interval [CI], 1.005, 1.034; p=0.01). BMI was not included in our prespecified multivariate model because of the low number of events. In univariate analysis, we found no statistically significant association between BMI and side-specific PSM (OR: 0.98; 95%CI, 0.88, 1.08; p=0.7). To analyze the effect of prostate side on PSM, we looked only at the 321 patients who had prostate cancer on both prostate lobes (n=642 prostate sides). In univariate analysis, we found no significant difference in risk of PSM between left and right sides (OR: 0.71; 95%CI, 0.36, 1.4; p=0.3).

Table 6.

Positive surgical margins according to degree of neurovascular bundle dissection

Intrafascial n (%) (n=594) Interfascial n (%) (n=85) Extrafascial n (%) (n=49) Total n (%) (n=728)
Location*
Anterior 8 (1.3) 1 (1.2) 0 (0) 9 (1.2)
Apex 12 (2.0) 8 (9.3) 3 (6.1) 23 (3.2)
Posterior 16 (2.7) 7 (8.1) 2 (4.1) 25 (3.4)
Bladder neck 0 (0) 0 (0) 1 (2.1) 1 (0.1)
Lateral 1 (0.2) 0 (0) 0 (0) 1 (0.1)
Total* 37* (6.2) 16* (18.6) 6* (12.2) 59* (8.1)
Biopsy Gleason sum
≤6 16/430 (4) 2/38 (5) 1/18 (6) 19/486 (4)
7 16/146 (11) 11/38 (29) 3/19 (16) 30/203 (15)
≥8 0/18 (0) 2/9 (22) 0/12 (0) 2/39 (5)
Total 32/594 (5) 15/85 (18) 4/49 (8) 51/728 (7)
Pathologic stage
Organ confined 21/523 (4) 6/55 (11) 0/31 (0) 27/609 (4)
ECE 11/71 (15) 9/30 (30) 4/18 (22) 24/119 (20)
Total 32/594 (5) 15/85 (18) 4/49 (8) 51/728 (7)

ECE=extracapsular extension.

* Includes locations of multiple positive surgical margins in the ipsilateral lobe.

4. Discussion

Several investigations have correlated preoperative findings with SM [10], [11], [12]; however, this is the first side-specific analysis of PSMs that also admits three degrees of NVB dissection: intrafascial (complete NVB sparing), interfascial (partial NVB sparing), and extrafascial (complete/almost complete NVB resection). This study contrasts with prior reports, which admitted two options: nerve sparing and non-nerve sparing [5], [6], [7]. This approach may be much more reliable because the current standards for prostate cancer surgery include tailoring the surgical technique to the side-specific preoperative clinical and biopsy data, trying to preserve the best possible quality of life [11]. In addition, few studies have evaluated the relation of MRI in conjunction with other preoperative parameters to predict PSM [3], [12].

Since the advent of conventional and robotically assisted LRP, PSM rates have been closely scrutinized, calling for a rigorous evaluation of factors affecting SM in a contemporary series [13].

It is reasonable to believe that the wider the dissection around the gland, the lower the chances of having a PSM; however, there is controversy in the literature [14]. In an open RP series, Villers and colleagues [9] decreased their PSMs from 21% to 6% by performing extrafascial dissection of the NVB among pT2 patients with tumour volume <2 cc. In opposition, Ward and colleagues [6] reported 34% and 42% PSM rates among patients undergoing nerve-sparing and wide NVB dissections, respectively. Similarly, Sofer and colleagues [5] described PSM rates of 24% and 31% among patients whose open RP was nerve sparing and non-nerve sparing, respectively. LRP reports are no less contradictory [7], [13], [15].

We found correlation between surgical techniques of nerve sparing and PSM. Although one would have predicted a lower PSM rate for those dissections in which an additional layer of fascia was presumably preserved (interfascial dissection), the opposite was observed. This observation is explained in part by differences in the patients selected among the three techniques as depicted in Table 7, in which prostate sides undergoing interfascial and extrafascial techniques had significantly higher proportions of biopsy Gleason scores 7–10 and more advanced clinical stages.

Table 7.

Comparison of clinical and intraoperative characteristics of patients undergoing intrafascial, interfascial, and extrafascial techniques

Intrafascial Interfascial Extrafascial p value
Age, yr. Median (IQR) 58 (53, 62) 61 (57, 66) 65 (61, 69) <0.001
PSA, ng/ml. Median (IQR) 5.3 (4.2, 6.8) 5.5 (4.5, 8.1) 5.1 (4.3, 8.7) 0.06
Biopsy gleason score, n (%)
≤6 or less 430 (72) 38 (45) 18 (37) <0.001
7 146 (25) 38 (45) 19 (39)
8–10 18 (3) 9 (10) 12 (24)
Clinical stage, n (%) <0.001
T1c 453 (76) 55 (65) 20 (41)
T2 136 (23) 26 (30) 24 (49)
T3 5 (1) 4 (5) 5 (10)
BMI, median (IQR) 27 (25, 30) 27 (25, 30)